Announced details
Drug discovery, cancer, fibrosis and regulation of protein-protein interactions (PPIs)
The Company's Representative Director will speak at the symposium organized by the counterparty.
Organizer. Location, representative, business description, capital and year established: Not disclosed
On-site venue: 3-2-1 Nihonbashi Muromachi, Chuo-ku, Tokyo, COREDO Muromachi Terrace 3F
On-site and online participation fees: ¥0 for LINK-J members and ¥5,000 for non-members
The company does not address Contract Value / Impact on Business Performance.
LINK-J event page
| Item | Details |
|---|---|
| Names of Products / Services Covered | PepMetics® compounds, PepMetics® |
| Counterparty | LINK-J |
| Counterparty overview | Organizer. Location, representative, business description, capital and year established: Not disclosed |
| Relationship with the Company | The Company's Representative Director will speak at the symposium organized by the counterparty. |
| Offering price | On-site and online participation fees: ¥0 for LINK-J members and ¥5,000 for non-members |
| Launch date | 3 July 2026 (scheduled event date) |
| Applicable area | Drug discovery, cancer, fibrosis and regulation of protein-protein interactions (PPIs) |
| Location | On-site venue: 3-2-1 Nihonbashi Muromachi, Chuo-ku, Tokyo, COREDO Muromachi Terrace 3F |
| Location scale | On-site capacity: 200 people; online capacity: 1,000 people |
| Source | LINK-J event page |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To promote dialogue with shareholders and investors and create opportunities to deepen understanding of the Company through proactive investor relations activities.